Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
CLBIO.STthis companyCorline Biomedical AB	SEK 12.80	-27.8×	4.33×	53.02×	-27.26×	-165.9%	-185.7%	-185.7%	-192.3%	-15.7%	-15.2%	-4.4%	0×	1.46×	0×	4.98×	0.0%	3	12.35	1	D+
ACE.STAscelia Pharma AB (publ)	SEK 0.53	-4.81×	3.67×	0×	-4.32×	-17.7%	0.0%	0.0%	0.0%	-76.7%	-73.4%	-19.8%	0.01×	0.67×	-13.46×	4.35×	0.0%	1	-8.91	2	C+
BACTI-B.STBactiguard Holding AB (publ)	SEK 15.55	-90.45×	2.21×	3.23×	18.08×	-178.3%	85.5%	-4.4%	-3.6%	-2.5%	-1.1%	-1.0%	0.52×	2.63×	-0.77×	1.67×	0.0%	8	0.28	2	C+
BIOWKS.STBio-Works Technologies AB (publ)	SEK 3.17	-15.41×	4.64×	3.66×	-11.76×	-1411.9%	76.5%	-28.0%	-24.4%	-31.0%	-31.6%	-8.4%	0×	2.12×	-90.77×	3.2×	0.0%	4	16.39	2	C
ELIC.STElicera Therapeutics AB (publ)	SEK 2.58	-13.74×	10.19×	0×	-12.25×	-80.7%	0.0%	0.0%	0.0%	-74.5%	-76.8%	-9.1%	0×	1.43×	-2,278.11×	6.75×	0.0%	1	32.08	1	C-
ENZY.STEnzymatica AB (publ)	SEK 2.40	-9.05×	3.71×	8.56×	-9.17×	-287.0%	61.5%	-96.9%	-96.3%	-41.8%	-41.7%	-8.9%	0.01×	0.69×	-42.41×	3.65×	0.0%	4	10.82	1	C-
Peer median	—	-13.74×	3.71×	3.23×	-9.17×	-178.3%	61.5%	-4.4%	-3.6%	-41.8%	-41.7%	-8.9%	0.01×	1.43×	-42.41×	3.65×	0.0%	4	10.82	2	—